Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Targeting DNA synthesis via thymidylate synthase inhibition using 5-fluorouracil exploits cancer cells' high demand for nucleotide precursors during rapid proliferation. The cytotoxic effect arises from both direct inhibition of thymidine production needed for new DNA strands and disruption caused by abnormal incorporation into both nuclear material and especially ribosomal RNA—a dual mechanism now recognized as central to its anticancer efficacy.
Irreversible inhibition of thymidylate synthase (TS) by FdUMP; misincorporation of FdUTP into DNA; incorporation of FUTP into RNA.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Synthesis (via 5-Fluorouracil).